169 related articles for article (PubMed ID: 7014458)
1. Role of antigen form in development of mucosal immunoglobin A response to Shigella flexneri Antigens.
Keren DF; Collins HH; Gemski P; Holt PS; Formal SB
Infect Immun; 1981 Mar; 31(3):1193-202. PubMed ID: 7014458
[TBL] [Abstract][Full Text] [Related]
2. Effect of antigen form on local immunoglobulin A memory response of intestinal secretions to Shigella flexneri.
Keren DF; McDonald RA; Scott PJ; Rosner AM; Strubel E
Infect Immun; 1985 Jan; 47(1):123-8. PubMed ID: 3880720
[TBL] [Abstract][Full Text] [Related]
3. Combined parenteral and oral immunization results in an enhanced mucosal immunoglobulin A response to Shigella flexneri.
Keren DF; McDonald RA; Carey JL
Infect Immun; 1988 Apr; 56(4):910-5. PubMed ID: 3278985
[TBL] [Abstract][Full Text] [Related]
4. Effect of parenteral immunization on the local immunoglobulin A response of the intestine to Shigella flexneri antigens.
Keren DF; Scott PJ; McDonald RA; Wiatrak M
Infect Immun; 1983 Oct; 42(1):202-7. PubMed ID: 6352492
[TBL] [Abstract][Full Text] [Related]
5. Local IgA-memory response to bacterial antigens.
Keren DF; Scott PJ; McDonald RA; Kern SE
Ann N Y Acad Sci; 1983 Jun; 409():734-44. PubMed ID: 6347004
[No Abstract] [Full Text] [Related]
6. Direct demonstration in intestinal secretions of an IgA memory response to orally administered Shigella flexneri antigens.
Keren DF; Kern SE; Bauer DH; Scott PJ; Porter P
J Immunol; 1982 Jan; 128(1):475-9. PubMed ID: 7033378
[No Abstract] [Full Text] [Related]
7. Local and systemic antibody responses to Shigella infection in rhesus monkeys.
Dinari G; Hale TL; Austin SW; Formal SB
J Infect Dis; 1987 May; 155(5):1065-9. PubMed ID: 3549918
[No Abstract] [Full Text] [Related]
8. The enteric immune response to shigella antigens.
Keren DF; McDonald RA; Wassef JS; Armstrong LR; Brown JE
Curr Top Microbiol Immunol; 1989; 146():213-23. PubMed ID: 2659270
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and protective efficacy offered by a ribosomal-based vaccine from Shigella flexneri 2a.
Shim DH; Chang SY; Park SM; Jang H; Carbis R; Czerkinsky C; Uematsu S; Akira S; Kweon MN
Vaccine; 2007 Jun; 25(25):4828-36. PubMed ID: 17507120
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2.
Kotloff KL; Losonsky GA; Nataro JP; Wasserman SS; Hale TL; Taylor DN; Newland JW; Sadoff JC; Formal SB; Levine MM
Vaccine; 1995 Apr; 13(5):495-502. PubMed ID: 7639017
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model.
Barry EM; Wang J; Wu T; Davis T; Levine MM
Vaccine; 2006 May; 24(18):3727-34. PubMed ID: 16169130
[TBL] [Abstract][Full Text] [Related]
12. IpaD-loaded N-trimethyl Chitosan Nanoparticles Can Efficiently Protect Guinea Pigs against Shigella flexneri.
Akbari MR; Saadati M; Honari H; Ghorbani HM
Iran J Immunol; 2019 Sep; 16(3):212-224. PubMed ID: 31552830
[TBL] [Abstract][Full Text] [Related]
13. Secretory IgA-mediated neutralization of Shigella flexneri prevents intestinal tissue destruction by down-regulating inflammatory circuits.
Boullier S; Tanguy M; Kadaoui KA; Caubet C; Sansonetti P; Corthésy B; Phalipon A
J Immunol; 2009 Nov; 183(9):5879-85. PubMed ID: 19828639
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of the live oral auxotrophic Shigella flexneri SFL124 in adult Vietnamese volunteers.
Li A; Kärnell A; Huan PT; Cam PD; Minh NB; Trâm LN; Quy NP; Trach DD; Karlsson K; Lindberg G
Vaccine; 1993; 11(2):180-9. PubMed ID: 8438616
[TBL] [Abstract][Full Text] [Related]
15. Live attenuated Shigella flexneri mutants as vaccine candidates against shigellosis and vectors for antigen delivery.
Phalipon A; Sansonetti P
Biologicals; 1995 Jun; 23(2):125-34. PubMed ID: 7546655
[TBL] [Abstract][Full Text] [Related]
16. Mucosal immune response in patients with dysentery.
Ciznar I; Qadri F; Hoque S; Bin AA; Schultsz C; Bartkova G
Adv Exp Med Biol; 1995; 371B():919-22. PubMed ID: 7502926
[No Abstract] [Full Text] [Related]
17. New animal model of shigellosis in the Guinea pig: its usefulness for protective efficacy studies.
Shim DH; Suzuki T; Chang SY; Park SM; Sansonetti PJ; Sasakawa C; Kweon MN
J Immunol; 2007 Feb; 178(4):2476-82. PubMed ID: 17277155
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of IgG class and subclass and IgA serum response to Shigella sonnei and Shigella flexneri 2a polysaccharides following vaccination with Shigella conjugate vaccines.
Robin G; Keisari Y; Slepon R; Ashkenazi S; Cohen D
Vaccine; 1999 Aug; 17(23-24):3109-15. PubMed ID: 10462247
[TBL] [Abstract][Full Text] [Related]
19. Local immune response and protection in the guinea pig keratoconjunctivitis model following immunization with Shigella vaccines.
Hartman AB; Van de Verg LL; Collins HH; Tang DB; Bendiuk NO; Taylor DN; Powell CJ
Infect Immun; 1994 Feb; 62(2):412-20. PubMed ID: 7507892
[TBL] [Abstract][Full Text] [Related]
20. Semiquantitative estimation of Shigella antigen-specific antibodies: correlation with disease severity during shigellosis.
Islam D; Wretlind B; Hammarström L; Christensson B; Lindberg AA
APMIS; 1996; 104(7-8):563-74. PubMed ID: 8920810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
